Puma Biotechnology reported $0.41 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.





Eps Change Date
Agios Pharmaceuticals USD -1.09 0.6 Sep/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amgen USD 6.45 0.16 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Daiichi Sankyo JPY 45.5 7.78 Sep/2026
Exelixis USD 0.94 0.03 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
Glaxosmithkline GBP 0.76 0.14 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
MacroGenics USD 0.31 0.89 Jun/2026
Moderna USD 0.38 2.35 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD 0.13 0.51 Sep/2026
Takeda JPY 116.95 45.3 Sep/2026
TG Therapeutics USD 0.35 0.3 Sep/2026
Ultragenyx Pharmaceutical USD -1.16 0.26 Sep/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026